Location: Home
  • search
  • go
  • Relate News
  • 12/22/2025NMPA Announces Revision of Montelukast Product Labels to Strengthen Dr...
  • 12/19/2025Recent Executive Moves
  • 12/19/2025U.S. Biosecurity Provisions Could Reshape China's Role in Global Biote...
  • 12/18/2025Sanofi's Aficamten Wins China Approval for Obstructive Hypertrophic Ca...
  • 12/18/2025Atom Thera Advances Anti-Inflammatory Pipeline With FDA Clearance for ...
  • 12/18/2025CSL Elevates China to Core Global Strategic Market
  • 12/18/2025China Grants First Global Approval to Cytokinetics' Cardiomyopathy Dru...
  • 12/18/2025HUTCHMED Initiates Global Clinical Development of FIC ATTC Candidate H...
  • 12/17/2025Hansoh and Glenmark Strike Multi-Regional Licensing Deal for EGFR Inhi...
  • 12/17/2025BMS Expands Antibody Pipeline Thru Global Collaboration With Harbour B...
  • 12/17/2025GE HealthCare Opens New R&D Center in Tianjin
  • 12/17/2025China Opens Consultation on First ICH M13A Low-Risk Formulation List f...
  • 12/17/2025CDE Solicits Comments on Draft Guidelines for Generic Ophthalmic Eye ...
  • 12/17/2025China Launches Pilot Program for Classified Management of Imported Foo...
  • 12/17/2025China's New Drug Commercial Insurance Scheme Offers Hope for Patients ...
  • 12/16/2025Fosun Moves to Acquire Maker of Controversial Alzheimer's Drug
  • 12/16/2025China Approves Genzyme's Fenthosilan Sodium Injection
  • 12/15/2025NHSA Unveils Three-Year Plan to Accelerate BMI Fund Clearing and Settl...
  • 12/15/2025Sino Biopharm Wins NMPA Approval for FIC Triple CDK Inhibitor in Breas...
  • 12/15/2025Qilu Wins Approval for China's First Fully Human Anti-EGFR Antibody
  • 12/15/2025CDE Solicits Comments on First Batch of ICH M13A Low-Risk Formulation ...
  • 12/12/2025CMS's NDA for Innovative Stroke Drug Y-3 for Injection Accepted in Ch...
  • 12/12/2025Recent Executive Moves
  • 12/11/2025Formation Bio Secures Global Rights to Lynk Pharma's CNS-Targeted TYK2...
  • 12/11/2025China Approves Boehringer Ingelheim's Jascayd for Progressive Pulmonar...
  • 12/11/2025Kelingyuan Reports Early Tumor Responses for Novel HER2-Targeted ADC S...
  • 12/11/2025Chinese Biopharma Sector Posts 22 Financings in November as In Vivo C...
  • 12/11/2025Innovative Drugs: The New Battleground in US-China Rivalry (ThinkChina...
  • 12/10/2025China Launches First Commercial Insurance Drug List, Spotlighting High...
  • 12/10/2025Lepu Reports Encouraging Phase II Results for CD20-Targeted ADC Combo
  • Page:3/376 Total number of articles:11273: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group